107 related articles for article (PubMed ID: 32014519)
1. Sensitivity and specificity of placental proteins for gestational age screening: An exploratory study.
Raymond EG; Frye LJ; Weaver MA; Lebed JP; Ren X; Steider E; Winikoff B; Barnhart KT
Contraception; 2020 May; 101(5):309-314. PubMed ID: 32014519
[TBL] [Abstract][Full Text] [Related]
2. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
Bersinger NA; Ødegård RA
Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
[TBL] [Abstract][Full Text] [Related]
3. Predicting first trimester pregnancy outcome: derivation of a multiple marker test.
Senapati S; Sammel MD; Butts SF; Takacs P; Chung K; Barnhart KT
Fertil Steril; 2016 Dec; 106(7):1725-1732.e3. PubMed ID: 28340932
[TBL] [Abstract][Full Text] [Related]
4. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
Yu N; Cui H; Chen X; Chang Y
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
[TBL] [Abstract][Full Text] [Related]
5. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
Pihl K; Larsen T; Krebs L; Christiansen M
Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
[TBL] [Abstract][Full Text] [Related]
6. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.
Cowans NJ; Spencer K
Prenat Diagn; 2007 Mar; 27(3):264-71. PubMed ID: 17278174
[TBL] [Abstract][Full Text] [Related]
7. First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus.
Syngelaki A; Kotecha R; Pastides A; Wright A; Nicolaides KH
Metabolism; 2015 Nov; 64(11):1485-9. PubMed ID: 26362726
[TBL] [Abstract][Full Text] [Related]
8. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.
Yliniemi A; Nurkkala MM; Kopman S; Korpimaki T; Kouru H; Ryynanen M; Marttala J
Metabolism; 2015 Apr; 64(4):521-6. PubMed ID: 25633269
[TBL] [Abstract][Full Text] [Related]
9. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
10. Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Prenat Diagn; 2010 May; 30(5):413-7. PubMed ID: 20306463
[TBL] [Abstract][Full Text] [Related]
11. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
[TBL] [Abstract][Full Text] [Related]
13. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
[TBL] [Abstract][Full Text] [Related]
14. Modeling Down syndrome screening performance using first-trimester serum markers.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
[TBL] [Abstract][Full Text] [Related]
15. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
[TBL] [Abstract][Full Text] [Related]
16. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
[TBL] [Abstract][Full Text] [Related]
17. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
[TBL] [Abstract][Full Text] [Related]
19. Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation.
Kuc S; Wortelboer EJ; Koster MP; de Valk HW; Schielen PC; Visser GH
BJOG; 2011 May; 118(6):748-54. PubMed ID: 21332636
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies.
Zaragoza E; Akolekar R; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):382-6. PubMed ID: 19277983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]